DOJ

Discussion in 'Mallinckrodt' started by anonymous, Jun 22, 2017 at 11:48 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    ARM cell phones subpoenaed, MNK will die quickly and hope they take personal ones next
     

  2. anonymous

    anonymous Guest

    DOJ needs to subpoena all complaints made to our compliance department via email that compliance never acted upon or would even investigate and if they did nothing changed. i am sure compliance has long erased those emails of complaints.
     
  3. anonymous

    anonymous Guest

    Why? Is the person or group still here? I am sure Compliance considers the source when receiving complaints. If you have a legitimate complaint i guarantee you it is investigated but many of the complaints come from disgruntled employees who are on their way out. Just leave already!
     
  4. anonymous

    anonymous Guest

    Well I guess that will be up to DOJ as to whether complaints were with merit or not and won't be up to you!
     
  5. anonymous

    anonymous Guest


    BAM!
     
  6. anonymous

    anonymous Guest

    DOJ needs to investigate the Compliance Department and all that is not "reported to the govt"
     
  7. anonymous

    anonymous Guest

    Hi, lots of worries about goal, so if you want to insure you make goal, heard that the Southeast Pulmonary division is telling docs to prescribe for 2-3 vials with 3-4 refills on form. That way they are insured for managed care approval. Seems it is working for them as the highest attainment ytd. Although would suspect this is a compliance issue as telling docs what to prescribe. Again, Up to OIG to investigate. If true, OIG only has to look at referrals for region and then ascertain where this direction is originating, if true.
     
  8. anonymous

    anonymous Guest

    I am sure this is being done
     
  9. anonymous

    anonymous Guest

    Why isn't compliance looking into the way the scripts are written on form? If they won't maybe DOJ will. Hope that high bonus check was worth it.
     
  10. anonymous

    anonymous Guest

    beacause aschook is posting this crap to justify his fake instigations to try to fire us, no one is stupid enough to do this any more
     
  11. anonymous

    anonymous Guest

    So is what you're saying is that you were stupid enough to do this previously. There is no statute of limitations for prosecution per FDA's policy on drug promotion, which does include telling a physician to prescribe in a manner that benefits an incentive plan for a representative vs patient need when there is no such standard or guideline per FDA. But I am sure noone needs to tell you something you already know.
     
  12. anonymous

    anonymous Guest

    MIAMI
     
  13. anonymous

    anonymous Guest

    I know lots going on with compliance and speaker programs. Would think doing 15 programs per quarter would be considered a kickback. (Yep now we know how some reps do it!) Know they are looking at reps with respect to this but wouldn't management be held accountable also since they have to approve additional programs above the minimum?
     
  14. anonymous

    anonymous Guest

    Let's see we pay physicians some of them speakers as well for "retrospective" data sets. There is a lot wrong here. That's just a tiny part.
     
  15. anonymous

    anonymous Guest

    There is nothing wrong with paying a MD for a retrospective analysis as long as the rules are followed.
     
  16. anonymous

    anonymous Guest


    At 1/2 a million to a million a year a company should have better data. Acthar would never get approval today. Period.
     
  17. anonymous

    anonymous Guest

    It's approved! Get over it!
     
  18. anonymous

    anonymous Guest

    What a weak response. Then again you must have something to hide. Anyone defending this anymore is insane.
     
  19. anonymous

    anonymous Guest

    Yea why aren't managers held accountable here?
     
  20. anonymous

    anonymous Guest

    good question!